Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 8,435 | 9,303 | 7,541 | 7,680 | 5,958 |
| Cost of Goods | 5,569 | 6,947 | 5,187 | 5,112 | 3,967 |
| Gross Profit | 2,866 | 2,356 | 2,354 | 2,568 | 1,990 |
| Operating Expenses | 4,542 | 4,571 | 3,892 | 3,843 | 3,737 |
| Operating Income | -1,106 | -1,268 | -1,351 | -1,163 | -780 |
| Interest Expense | 0 | 0 | 49 | 54 | 39 |
| Other Income | 124 | 431 | 138 | 188 | 208 |
| Pre-tax Income | -983 | -838 | -1,261 | -1,030 | -611 |
| Income Tax | 215 | -344 | 22 | 220 | 41 |
| Net Income Continuous | -1,198 | -494 | -1,284 | -1,250 | -652 |
| Net Income | $-1,198 | $-494 | $-1,284 | $-1,250 | $-652 |
| EPS Basic Total Ops | -0.94 | -9.94 | -2.00 | -74.87 | -50.72 |
| EPS Basic Continuous Ops | -0.94 | -9.94 | -2.00 | -75.30 | -50.11 |
| EPS Diluted Total Ops | -0.94 | -9.94 | -2.00 | -74.87 | -50.72 |
| EPS Diluted Continuous Ops | -0.94 | -9.94 | -2.00 | -75.30 | -50.11 |
| EPS Diluted Before Non-Recurring Items | -0.94 | -9.94 | -40.00 | -100.00 | N/A |
| EBITDA(a) | $-1,042 | $-1,217 | $-1,308 | $-1,121 | $-742 |